Who are Bisacodyl 5 milligram's main competitors?

Direct comparators (same drug class / molecular target / therapeutic area): Senna tablets, Senna alone, Dulcolax (Bisacodyl).

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/bisacodyl-5-milligram.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-05-16 · How we verify

Bisacodyl 5 milligram — Competitive Intelligence Brief

Bisacodyl 5 milligram (Bisacodyl 5 milligram) competitive landscape: 3 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Contact laxative. Area: Gastroenterology.

marketed Contact laxative Colonic smooth muscle and intestinal epithelium Gastroenterology Small molecule Live · refreshed every 30 min

Target snapshot

Bisacodyl 5 milligram (Bisacodyl 5 milligram) — University of Nottingham. Bisacodyl stimulates colonic muscle contractions and increases intestinal fluid secretion to promote bowel evacuation.

Comparator set (3 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target
Bisacodyl 5 milligram TARGET	Bisacodyl 5 milligram	University of Nottingham	marketed	Contact laxative	Colonic smooth muscle and intestinal epithelium
Senna tablets	Senna tablets	Medtronic - MITG	marketed	Stimulant laxative	Colonic smooth muscle and intestinal epithelium
Senna alone	Senna alone	Camlıca Erdem Hospital	marketed	Stimulant laxative	Colonic smooth muscle and intestinal epithelium
Dulcolax (Bisacodyl)	Dulcolax (Bisacodyl)	Brooke Army Medical Center	marketed	Contact laxative	Myenteric plexus; intestinal smooth muscle

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Contact laxative class)

Brooke Army Medical Center · 1 drug in this class
University of Nottingham · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Bisacodyl 5 milligram — Competitive Intelligence Brief. https://druglandscape.com/ci/bisacodyl-5-milligram. Accessed 2026-05-16.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab